NeuroNews’ top 10 most popular stories of July 2024

Industry updates—including several revealed during this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA)—garnered much of our readers’ attention...

Cost-flexible devices and boosting thrombectomy uptake in the developing world

The growth of intravenous thrombolysis (IVT) coupled with the advent—and ongoing expansion—of mechanical thrombectomy has seen acute stroke transform from “a diagnosable and hardly...

The modified Rankin scale as a stroke trial endpoint: important, but not all-encompassing

The modified Rankin scale (mRS) is something of a default clinical outcome metric in many contemporary stroke studies, but—as Eva Mistry and Paul Wechsler...

NeuroNews’ top 10 most popular stories of June 2024

A number of major players in the neurovascular device industry—including Medtronic, Microvention/Terumo and Penumbra—announced newly launched technologies throughout June. These updates, coupled with insights...

NeuroNews’ top 10 most popular stories of May 2024

Global conference coverage piqued NeuroNews readers’ interest through the month of May—initially with discussions at the Charing Cross (CX) International Symposium (23–25 April, London,...

Positive HEMERA-1 data pave the way for further neuroprotection trials during ‘thrombectomy era’

Following the recent publication in Stroke: Vascular and Interventional Neurology of results from HEMERA-1, a prospective, multicentre trial evaluating the safety of novel neuroprotective...

Varied tenecteplase data may provide clarity on the drug’s exact role in acute stroke...

This year’s European Stroke Organisation Conference (ESOC; 15–17 May, Basel, Switzerland) saw a plethora of data on intravenous tenecteplase—from studies spanning Australia, Canada, China,...

Stroke transfer protocols: what does the road ahead look like?

A number of somewhat conflicting studies have been published over the past year regarding triage and transport protocols for stroke. In light of the...

NeuroNews’ top 10 most popular stories of April 2024

NeuroNews’ top 10 most popular stories of April 2024 include the European launch of a new aspiration catheter for acute ischaemic stroke treatment, a...

First European PERFORMANCE II release highlights durability of carotid stenting in high-risk patients

The recent, first-time European presentation of the PERFORMANCE II trial’s findings—delivered by Ralf Langhoff (Sankt Gertrauden-Krankenhaus, Berlin, Germany) at the 2024 Charing Cross (CX)...

NeuroNews’ top 10 most popular stories of March 2024

Major pieces of industry news from a number of innovators in the neurovascular space populate NeuroNews’ top 10 articles of last month—including NeuroOne, Artiria,...

Debates, case carousel and European first head up CX carotid and acute stroke programme

The programme for the 2024 Charing Cross (CX) symposium (23–25 April, London, UK) will see the topics of acute stroke care, carotid disease and...

Shining a light on hereditary brain aneurysms

Intracranial aneurysms are a largely underestimated condition, for which global awareness and clinical research are currently lacking—and these sentiments apply even more pertinently when...

NeuroNews’ top 10 most popular stories of February 2024

Our list of the most popular stories from last month is dominated by first-time data releases from the International Stroke Conference (ISC; 7–9 February,...

No-reflow in clinical studies: Causes, rates and implications for patient outcomes

In a guest article for NeuroNews, Adnan Mujanovic (Bern, Switzerland) discusses a relatively unknown but potentially significant factor in stroke patients experiencing poor clinical...

Advancing neurosurgery inside and outside the operating room

Brian Nahed (Boston, USA) outlines the latest advances in neurosurgery, and why it is important for those working in the field to keep up...